James Gulley

28.7k citations
458 papers · 21.5k · 6 hit papers · h-index 79

Impact in

  • Oncology top 0.1%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
  • Immunology top 0.1%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction

Papers in

    • Cancer Immunotherapy and Biomarkers 156
    • CAR-T cell therapy research 47
    • Immunotherapy and Immune Responses 148
    • Immune Cell Function and Interaction 24
    • T-cell and B-cell Immunology 17

James Gulley

441 papers receiving 21.0k citations

James Gulley's Hit Papers

Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision 2024 · 114 citations
1140+5+10Years since publication250500750

Peers

James Gulley
Comparison fields: 5 of 153
  • Oncology 10.8k
  • Immunology 8.0k
  • Pulmonary and Respiratory Medicine 5.4k
  • Cancer Research 1.7k
  • Radiology, Nuclear Medicine and Imaging 1.7k
Replace Aurélien Marabelle with:
Aurélien Marabelle France
Andreas Daniel Hartkopf Germany
Dirk Jäger Germany
Ulrich Keilholz Germany
Anne Katrin Berger France
Wallace A. Akerley United States
Barbara Ann Burtness United States
Bruno Sangro Spain
Sandra Demaria United States
Harriet M. Kluger United States
James Gulley relative to Aurélien Marabelle France Aurélien Marabelle's profile →
Citations per field
00.5×1.5×1.8×
Aurélien Marabelle · 1×
Citations per year

Countries citing papers authored by James Gulley

Since Specialization
Citations

This map shows the geographic impact of James Gulley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Gulley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Gulley more than expected).

Fields of papers citing papers by James Gulley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Gulley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Gulley. The network helps show where James Gulley may publish in the future.

Co-authors

The 25 scholars most cited alongside James Gulley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James Gulley Line = papers co-authored together James Gulley links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 458 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
Hit paper breakdown →
2010806
2
Avelumab, an Anti–Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study
Hit paper breakdown →
2017511
3
Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial
Hit paper breakdown →
2017485
4 2015403
5
Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer
Hit paper breakdown →
2019374
6 2018354
7 2019315
8 2005309
9 2012293
10 2019291
11 2004271
12 2017259
13 2004251
14 2017249
15 2018248
16 2006247
17 2009247
18 2020233
19 2019226
20 2019223

About James Gulley

James Gulley is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 458 papers that have together received 21.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (156 papers), Immunotherapy and Immune Responses (148 papers), Prostate Cancer Treatment and Research (112 papers), CAR-T cell therapy research (47 papers), vaccines and immunoinformatics approaches (29 papers), Prostate Cancer Diagnosis and Treatment (25 papers), Immune Cell Function and Interaction (24 papers) and T-cell and B-cell Immunology (17 papers). The work is most often cited by research in Oncology (10.8k citations), Immunology (8.0k citations), Pulmonary and Respiratory Medicine (5.4k citations), Cancer Research (1.7k citations) and Radiology, Nuclear Medicine and Imaging (1.7k citations). James Gulley has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Jeffrey Schlom, Ravi Amrit Madan, Philip Martin Arlen, William L. Dahut, Seth M. Steinberg, Christopher Ryan Heery, Caroline Jochéms, Kwong Yok Tsang, James W. Hodge and Renee Nicole Donahue. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Clinical Cancer Research, Annals of Oncology, The Oncologist and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact